首页> 中文期刊>TMR药理学研究 >Verapamil: a promising therapeutic option in diabetes mellitus type 1?

Verapamil: a promising therapeutic option in diabetes mellitus type 1?

     

摘要

Type 1A diabetes mellitus(DMT1 in the following text)is caused by the autoimmune destruction of the insulin-producing beta cells in the islets of Langerhans[1,2].This destruction is determined by genetic susceptibility,such as the presence of HLA-DQalpha,HLA-DQbeta,HLA-DR,preproinsulin,PTPN22 gene,CTLA-4,interferon-induced helicase,IL2 receptor(CD25),lectin-like gene(KIAA0035),and ERBB3e[3–8].It is usually triggered by environmental agents,such as perinatal factors(maternal age over 25 years,preeclampsia,neonatal respiratory disease,and jaundice),viruses(Coxsackie virus,enteroviruses),dietary factors(cow’s milk),exposure to nitrates,and treatment with checkpoint inhibitors[9–14].

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号